| Naslov: | Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches |
|---|
| Avtorji: | ID Hira, Vashendriya V. V. (Avtor)
ID Noorden, Cornelis J. F. van (Avtor)
ID Carraway, Hetty E. (Avtor)
ID Maciejewski, Jaroslaw P. (Avtor)
ID Molenaar, Remco J. (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0304419X1630124X?via%3Dihub
 PDF - Predstavitvena datoteka, prenos (1,69 MB)
MD5: EF8B282F389F5BC262619AD3144429D6
URL - Izvorni URL, za dostop obiščite https://doi.org/10.1016/j.bbcan.2017.03.010
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: |  NIB - Nacionalni inštitut za biologijo
|
|---|
| Povzetek: | Acute myeloid leukemia and acute lymphoblastic leukemia cells hijack hematopoietic stem cell (HSC) niches in the bone marrow and become leukemic stem cells (LSCs) at the expense of normal HSCs. LSCs are quiescent and resistant to chemotherapy and can cause relapse of the disease. HSCs in niches are needed to generate blood cell precursors that are committed to unilineage differentiation and eventually production of mature blood cells, including red blood cells, megakaryocytes, myeloid cells and lymphocytes. Thus far, three types of HSC niches are recognized: endosteal, reticular and perivascular niches. However, we argue here that there is only one type of HSC niche, which consists of a periarteriolar compartment and a perisinusoidal compartment. In the periarteriolar compartment, hypoxia and low levels of reactive oxygen species preserve the HSC pool. In the perisinusoidal compartment, hypoxia in combination with higher levels of reactive oxygen species enables proliferation of progenitor cells and their mobilization into the circulation. Because HSC niches offer protection to LSCs against chemotherapy, we review novel therapeutic strategies to inhibit homing of LSCs in niches for the prevention of dedifferentiation of leukemic cells into LSCs and to stimulate migration of leukemic cells out of niches. These strategies enhance differentiation and proliferation and thus sensitize leukemic cells to chemotherapy. Finally, we list clinical trials of therapies that tackle LSCs in HSC niches to circumvent their protection against chemotherapy. |
|---|
| Ključne besede: | hematopoietic stem cell niche, hijacking, leukemic stem cells, bone marrow, therapy resistance, leukemia |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.08.2017 |
|---|
| Leto izida: | 2017 |
|---|
| Št. strani: | str. 183-198 |
|---|
| Številčenje: | Vol. 1868, iss. 1 |
|---|
| PID: | 20.500.12556/DiRROS-20138  |
|---|
| UDK: | 61 |
|---|
| ISSN pri članku: | 0304-419X |
|---|
| DOI: | 10.1016/j.bbcan.2017.03.010 |
|---|
| COBISS.SI-ID: | 40483077 |
|---|
| Datum objave v DiRROS: | 06.08.2024 |
|---|
| Število ogledov: | 271 |
|---|
| Število prenosov: | 224 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
